Synthorx is advancing the breakthrough technology of synthetic DNA bases that can be replicated in vivo for numerous medical and technological applications. The ability to incorporate and replicate a synthetic DNA base pair in vivo means that for the first time thegenetic alphabet has been expanded to increase the amount of information that can be stored in DNA to improve the discovery and development of new drugs, diagnostics and vaccines as well as creating innovative products, including research reagents, aptamers and nanomaterials.









